Thrivent Financial for Lutherans’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Buy |
69,399
+905
| +1% | +$66.4K | 0.01% | 823 |
|
|
2025
Q1 | $7.82M | Sell |
68,494
-3,583
| -5% | -$409K | 0.02% | 683 |
|
|
2024
Q4 | $3.63M | Sell |
72,077
-953
| -1% | -$48K | 0.01% | 1066 |
|
|
2024
Q3 | $3.38M | Sell |
73,030
-3,027
| -4% | -$140K | 0.01% | 1117 |
|
|
2024
Q2 | $2.47M | Sell |
76,057
-2,637
| -3% | -$85.7K | 0.01% | 1247 |
|
|
2024
Q1 | $1.98M | Sell |
78,694
-1,718
| -2% | -$43.3K | ﹤0.01% | 1425 |
|
|
2023
Q4 | $2.61M | Sell |
80,412
-2,141
| -3% | -$69.5K | 0.01% | 1203 |
|
|
2023
Q3 | $2.25M | Sell |
82,553
-3,930
| -5% | -$107K | 0.01% | 1221 |
|
|
2023
Q2 | $1.92M | Sell |
86,483
-8,465
| -9% | -$188K | ﹤0.01% | 1364 |
|
|
2023
Q1 | $2.06M | Sell |
94,948
-3,327
| -3% | -$72.1K | 0.01% | 1279 |
|
|
2022
Q4 | $2M | Sell |
98,275
-262
| -0.3% | -$5.32K | 0.01% | 1263 |
|
|
2022
Q3 | $2.53M | Buy |
98,537
+4,588
| +5% | +$118K | 0.01% | 1090 |
|
|
2022
Q2 | $2.23M | Buy |
93,949
+16,335
| +21% | +$388K | 0.01% | 1169 |
|
|
2022
Q1 | $1.75M | Buy |
77,614
+378
| +0.5% | +$8.51K | ﹤0.01% | 1415 |
|
|
2021
Q4 | $1.53M | Sell |
77,236
-7,098
| -8% | -$141K | ﹤0.01% | 1581 |
|
|
2021
Q3 | $1.66M | Sell |
84,334
-1,477
| -2% | -$29.1K | ﹤0.01% | 1478 |
|
|
2021
Q2 | $1.89M | Sell |
85,811
-920
| -1% | -$20.2K | ﹤0.01% | 1458 |
|
|
2021
Q1 | $2.06M | Buy |
86,731
+188
| +0.2% | +$4.47K | ﹤0.01% | 1405 |
|
|
2020
Q4 | $2.26M | Buy |
86,543
+306
| +0.4% | +$8.01K | 0.01% | 1237 |
|
|
2020
Q3 | $1.5M | Sell |
86,237
-95
| -0.1% | -$1.65K | ﹤0.01% | 1325 |
|
|
2020
Q2 | $1.45M | Buy |
86,332
+132
| +0.2% | +$2.22K | ﹤0.01% | 1253 |
|
|
2020
Q1 | $1.03M | Buy |
86,200
+4,303
| +5% | +$51.2K | ﹤0.01% | 1289 |
|
|
2019
Q4 | $991K | Buy |
81,897
+598
| +0.7% | +$7.24K | ﹤0.01% | 1498 |
|
|
2019
Q3 | $1.15M | Sell |
81,299
-603
| -0.7% | -$8.52K | ﹤0.01% | 1316 |
|
|
2019
Q2 | $913K | Buy |
81,902
+1,616
| +2% | +$18K | ﹤0.01% | 1471 |
|
|
2019
Q1 | $943K | Buy |
80,286
+6,625
| +9% | +$77.8K | ﹤0.01% | 1415 |
|
|
2018
Q4 | $984K | Buy |
73,661
+1,620
| +2% | +$21.6K | ﹤0.01% | 1162 |
|
|
2018
Q3 | $1.01M | Buy |
72,041
+6,429
| +10% | +$90.1K | ﹤0.01% | 1276 |
|
|
2018
Q2 | $1.03M | Buy |
65,612
+1,383
| +2% | +$21.7K | ﹤0.01% | 1239 |
|
|
2018
Q1 | $1.06M | Buy |
64,229
+7,166
| +13% | +$118K | ﹤0.01% | 1208 |
|
|
2017
Q4 | $1.03M | Buy |
+57,063
| New | +$1.03M | ﹤0.01% | 1232 |
|